Underwriter takes all extra Vogenx (VOGX) IPO shares
Rhea-AI Filing Summary
Vogenx, Inc. (VOGX) reports that JonesTrading Institutional Services LLC fully exercised its 45‑day over‑allotment option related to Vogenx’s recent initial public offering. The option covered 937,500 additional shares of common stock at a public offering price of $13.00 per share, closing on August 19, 2026 and generating additional gross proceeds of approximately $12,187,500 before underwriting discounts, commissions and expenses. Including these shares, a total of 7,187,500 shares have been issued and sold in the offering, for aggregate gross proceeds of approximately $93,437,500.
Positive
- Full exercise of over-allotment increases IPO gross proceeds to approximately $93,437,500, expanding Vogenx’s capital base.
- Additional 937,500 shares sold at the IPO price of $13.00 per share indicate sufficient demand to support the full over-allotment.
Negative
- None.
Filing Explained
Because the fully exercised over-allotment option resulted in 937,500 additional common shares being issued and sold, the offering now totals 7,187,500 shares; issuing those shares increases the total share count and reduces existing holders’ percentage ownership, absent offsetting changes.
8-K Event Classification
Item 8.01 — Other Events
1 item
Item 8.01
Other Events
Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Key Figures
Base IPO shares sold: 6,250,000 shares
Over-allotment shares: 937,500 shares
Total shares sold in offering: 7,187,500 shares
+4 more
7 metrics
Base IPO shares sold
6,250,000 shares
Initial public offering completed on August 13, 2026
Over-allotment shares
937,500 shares
Additional shares sold upon full exercise of over-allotment option on August 19, 2026
Total shares sold in offering
7,187,500 shares
Aggregate common shares issued in IPO including over-allotment
IPO price per share
$13.00 per share
Public offering price for both base and over-allotment shares
Base IPO gross proceeds
$81,250,000
Gross proceeds from 6,250,000 shares before underwriting discounts and expenses
Over-allotment gross proceeds
$12,187,500
Additional gross proceeds from 937,500 shares before underwriting discounts and expenses
Total gross proceeds
$93,437,500
Aggregate IPO gross proceeds including full exercise of over-allotment option
Key Terms
initial public offering, Over-Allotment Option, underwriting agreement, emerging growth company
4 terms
initial public offering financial
"consummated its initial public offering (the “Offering”) of 6,250,000 shares"
An initial public offering (IPO) is when a private company first sells its shares to the public and becomes a stock-listed company. It matters because it allows the company to raise money from a wide range of investors, helping it grow, while giving early shareholders a way to sell some of their ownership.
Over-Allotment Option financial
"the Company granted the Underwriter a 45-day option to purchase up to 937,500 additional shares of common stock at the public offering price of $13.00 (the “Over-Allotment Option”)"
An over-allotment option is a special agreement that allows underwriters to sell more shares than initially planned if demand is high. Think of it like a retailer offering extra units of a popular product to meet additional customer interest. This option helps ensure the full sale is completed and can also give investors extra shares if they want more.
underwriting agreement financial
"underwriting agreement dated August 11, 2026 (the “Underwriting Agreement”)"
An underwriting agreement is a contract where a company selling new stocks or bonds hires financial firms to buy those securities and resell them to investors. It matters because the agreement sets the offering price, number of securities, fees and which party bears the risk if sales fall short—think of it as a promise that the sale will happen and a roadmap investors can use to understand how the new securities reach the market.
emerging growth company regulatory
"Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
FAQ
What did Vogenx, Inc. (VOGX) announce regarding its IPO over-allotment option?
Vogenx announced that the underwriter fully exercised its IPO over-allotment option for 937,500 additional shares at $13.00 per share, providing about $12,187,500 in additional gross proceeds before underwriting discounts, commissions and offering expenses.
What are the total gross proceeds from VOGX’s IPO after the over-allotment exercise?
Total gross proceeds from Vogenx’s offering are approximately $93,437,500. This includes $81,250,000 from the initial 6,250,000 shares and about $12,187,500 from the 937,500 over-allotment shares, all before underwriting discounts and expenses.
Who was the underwriter for VOGX’s IPO and over-allotment option?
JonesTrading Institutional Services LLC acted as underwriter for Vogenx’s offering. Under the underwriting agreement, it held a 45‑day option to purchase up to 937,500 additional shares, which it fully exercised on August 19, 2026.
AI-generated analysis. How Rhea-AI works. Not financial advice.
